Melissa has been with BBI for over 15 years, with technical experience in antibody development, manufacturing, and process development working to help bring customers products and services that meet their individual needs.

She currently serves as senior product manager for the Disease Agnostic portfolio including HRP, ALP, Gold, & Polystreptavidin. She is a qualified scientist (MSc in Applied Medical Sciences) and strives to add value to the global life sciences industry doing her small part to help BBI’s customers reach their innovative goals.​

Join Melissa in “Beyond Streptavidin” to discover how BBI’s polystreptavidin is enhancing sensitivity in lateral flow and delivering greater consistency. This talk will include insights into BBI’s polymerized recombinant streptavidin reagent, which offers improved sensitivity and greater stability. Gila Biosciences, with over 40 years experience in advancing rapid point-of-care testing, will present comparative data highlighting how Polystreptavidin outperforms traditional Streptavidin by improving the limit of detection and reducing reagent consumption.

As CEO of BBI, Alex brings over 33 years of global leadership in the healthcare industry, spanning In-Vitro Diagnostics, Medical Devices, and Life Sciences. With a career built across the Americas, EMEA, and Asia-Pacific, he has a proven track record in driving growth, building high-performing teams, and leading transformational change. His expertise in global strategy, innovation, and operational excellence has helped shape BBI into the trusted partner it is today.

In “Beyond the Logo: Where Our Values Meet Your Needs,” Alex shares how BBI's purpose and principles are reflected in the way we work with our IVD and life sciences partners every day. It’s an open conversation-with an open bar-designed to connect, reflect, and look ahead.

Simon is the Commercial Technical Lead for BBI antigen products, supporting clients with technical reagent solutions for antigens, serum and plasma products and specific cell culture media supplements within the BBI portfolio of products.

As part of the team that developed many of the purification strategies and defined the product analytical specifications, Simon has a broad background in Biomedical Sciences. He has worked for BBI for over 30 years, has a comprehensive knowledge of the IVD industry, is a long-term member of the ADLM and has participated in various global protein biomarker standardisation projects.

“Haemoglobin Testing in Diabetes – Why the Details Matter” explores the growing global prevalence of diabetes and the importance of understanding diagnostic tools used to monitor this disease. The presentation provides an overview of biomarkers and methodologies used in clinical settings, with a focus on HbA1c. It also highlights the unique reagents that BBI offers to support IVD companies in the development of accurate and reliable testing methods.

Tinus has been with BBI for over 15 years, with experience in development and bulk manufacturing/purification of natural enzymes and proteins from various biological materials.

He currently serves as the site lead for the South African operation. He is a qualified biochemist (MSc in medical biochemistry) and strives to add value to the global healthcare and diagnostics industry.

In his masterclass, “70 Years of HRP You Can Trust,One Partner. Every Diagnostic Need Covered” Tinus explores our comprehensive HRP offering. Covering every diagnostic need with proven performance, reliable supply, and a legacy of innovation.

Andrew has spent 16 years leading R&D and Product Management teams in the life science and in-vitro diagnostics sectors, specifically reagent management for IHC and molecular diagnostic applications.

At BBI he is the Product Management Director, responsible for portfolio strategy and roadmap development.

Join Andrew in “Humanized Chimeric Antibodies: Security for your Assay Controls” for a focused look at how antibodies are shaping the future of assay reliability and control strategy.

Andy has spent 17 years working with reagents in the research and in-vitro diagnostics sectors, supplying manufacturers with both bespoke and ready-made antibodies, antigens and enzymes.

At BBI he is a product manager responsible for products focussed on clinical chemistry, diabetes and biosensor applications. Working closely with our development and commercial teams he enjoys connecting customer needs with our manufacturing expertise.

Join Andy’s masterclass, “Utility in Design: Reagents for Diabetes Testing” for expert insights on reagent design, an in-depth look at GLD and GO grades, and a sneak peek into BBI’s development pipeline.